Friday

190426

Workout of the Day

1

Rest Day

Post thoughts to comments.

Eroom's Law

3

In this 2012 review, Jack W. Scannell, Alex Blanckley, Helen Boldon, and Brian Warrington discuss “Eroom’s Law,” which focuses on the drug market instead of technology and is the opposite of Moore’s Law in name and concept: The cost of developing a new drug doubles approximately every nine years, indicating that the number of drugs approved per billion dollars spent has fallen 80-fold since 1950. The authors review four major factors for this phenomenon.

Read MoreEroom's Law

Comments on 190426

4 Comments

Comment thread URL copied!
Matthieu Dubreucq
January 2nd, 2020 at 2:05 pm
Commented on: Eroom's Law

The problem I see is if it costs more to develop the drug the Pharma compagnies will want more money out of the drug and are more likely to "push" science the way they want it to go to get a better return on investment.

Comment URL copied!
Stacey Carpenter
April 28th, 2019 at 9:04 pm
Commented on: 190426

32nd Birthday Stacey

partner Pat

max DL & WB run320 m

max OHS & Row 320m

max Snatch & 32 Box Jumps

max P.cleans & 32 Burpees

105dl 55 rest bb moves

8:19 my round bb Rd 10:40 cardio Rd

total time 109 reps for me in barbell

one max reps while other completes sets then switch at the end of it and swap places

Comment URL copied!
NA
April 26th, 2019 at 5:36 pm
Commented on: Eroom's Law

This article is certainly not giving readers the entire picture. My point in my response is that there are amazing new treatments to disease due to novel drug discovery. Finding these solutions should be considered more of a miracle than an expectation.


Since 1963 the FDA has consistently approved 40-100 novel drugs per year. This doesn’t include the new applications for existing drugs that are currently on patent. The cost of bringing a novel drug to market in 1998 was 500 million dollars and would take close to 15 years. This doesn’t include the additional time for a drug to be discovered and its potential applications based upon its biological activity. Inflation in costs to bring a drug to market needs to include more strict FDA requirements, rising costs of HPLC columns and instrumentation, increase in researcher salaries, increase in raw materials, etc.


The fact of the matter is that providers can now treat diseases today where treatments were either poor or non existent 20-30 years ago. The real questions to consider are these.


1. Brand name and their generic versions are not exact equivalent.


2. Drug costs to consumers in America versus markets like Asia.

Comment URL copied!
Salvador Camacho
April 26th, 2019 at 7:00 am
Commented on: Eroom's Law

And how exactly this relates to the CF philosophy? I am missing the point here, sorry.

Comment URL copied!